A patient with an overactive bladder has recently started taking oxybutynin.
What observation should the practical nurse (PN) report to the charge nurse during the patient’s assessment prior to administering the medication?
Diminished urinary urgency.
Reduced urinary frequency.
Decreased urinary output.
Less frequent urinary incontinence.
The Correct Answer is C
Choice A rationale
Diminished urinary urgency is an expected outcome of oxybutynin treatment, as the
medication works by relaxing the muscles of the bladder.
Choice B rationale
Reduced urinary frequency is another expected outcome of oxybutynin treatment.
Choice C rationale
Decreased urinary output is not a typical effect of oxybutynin. In fact, oxybutynin is used to
manage symptoms of an overactive bladder, which include frequent urination. Therefore, if the
PN observes decreased urinary output, it could indicate a problem such as urinary retention,
which should be reported to the charge nurse.
Choice D rationale
Less frequent urinary incontinence is an expected outcome of oxybutynin treatment.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A rationale
The patient is receiving a nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) for HIV
treatment and reports experiencing malaise, fatigue, and anorexia. These symptoms, along
with the observed increased respiratory rate, could be indicative of liver toxicity, a known
potential side effect of NRTIs. Therefore, reviewing liver function tests would be most
important in this case.
Choice B rationale
While arterial blood gases can provide valuable information about a patient’s respiratory
status, they may not be the most relevant in this context. The patient’s symptoms and the side
effect profile of NRTIs suggest that liver function may be a more pressing concern.
Choice C rationale
A complete blood count (CBC) can provide a broad overview of a patient’s general health, but it
may not provide the specific information needed to assess the patient’s current symptoms and
potential medication side effects.
Choice D rationale
A basic metabolic panel can provide information about a patient’s kidney function, electrolyte
levels, and blood sugar levels, among other things. However, given the patient’s symptoms and
medication regimen, liver function tests may be more relevant.
Correct Answer is B
Explanation
Choice A rationale
Montelukast does not increase the production of mucus in the lungs. In fact, it helps to reduce inflammation and may be used to prevent asthma attacks.
Choice B rationale
Montelukast is a leukotriene modifier that helps to reduce inflammation and prevent asthma attacks and exercise-induced bronchoconstriction. It works by blocking the action of leukotriene D4 in the lungs resulting in decreased inflammation and relaxation of smooth muscle. This prophylactic limitation of the inflammatory response to allergens is a key function of montelukast.
Choice C rationale
Montelukast does not contract the smooth muscles located in the respiratory tract. Instead, it helps to relax the smooth muscles in the lungs, reducing inflammation and making it easier to breathe.
Choice D rationale
Montelukast does not directly repair damaged tissue in the base of the lungs. Its primary function is to prevent and manage symptoms of asthma and allergies by reducing inflammation in the airways.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.